This presentation will focus on psilocybin, its therapeutic uses and outcomes in various settings for people with a variety of mental health related challenges. How essential is the psychotherapy for the process of change, and what sets it aside from other approaches? The presentation will also cover the key elements in training therapists for this work and why they are important.
Renee Harvey is a highly experienced clinical psychologist who relocated from the UK to Australia to develop training in psychedelic-assisted psychotherapy (PAP). She has many years of experience as a lecturer, trainer, clinician and service developer within the mental health field. Her ideas on PAP training are featured in a recently published book chapter (Harvey, 2021) and in various talks and podcasts.
Prior to relocation, Renee was an Honorary Research Fellow and assistant guide in the Imperial College London trial researching psilocybin for treatment-resistant depression. She also facilitated the development of psychedelic interest groups and established and ran a psychedelic Integration Circle in Brighton.
Renee is currently assisting as a therapist on the psilocybin trials at St Vincent’s Hospital, Melbourne, aimed at the alleviation of depression and anxiety associated with life-threatening illness. She is also on the Clinical Advisory Board of Reset Mind Sciences, providing therapist training for their psychedelic research program. She also has a private practice in Melbourne with an emphasis on providing psychedelic integration.